Recombinant tumour necrosis factor-α and platelet-activating factor synergistically increase intercellular adhesion molecule-1 and E-selectin-dependent neutrophil adherence to endothelium in vitro

Immunology

Volumn 87, Issue 3, 1996, Pages 454-460

  Sterner Kock, A ^a   Braun, R K ^a   Schrenzel, M D ^a   Hyde, D M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 O ALKYLGLYCERO 3 PHOSPHORYLCHOLINE; APAFANT; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; THROMBOCYTE ACTIVATING FACTOR;

ADULT; ARTICLE; CELL ADHESION; ENDOTHELIUM; HUMAN; HUMAN CELL; NEUTROPHIL; NEWBORN; NORMAL HUMAN; PRIORITY JOURNAL; UMBILICAL VEIN;

CELL ADHESION; CELLS, CULTURED; DRUG SYNERGISM; E-SELECTIN; ENDOTHELIUM, VASCULAR; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; NEUTROPHILS; PLATELET ACTIVATING FACTOR; RECOMBINANT PROTEINS; STIMULATION, CHEMICAL; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 0030010351     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. TRACEY K.J., BEUTLER B., LOWRY S.F. et al. (1986) Shock and tissue injury induced by recombinant human cachectin. Science 234, 470.
2. WALZ G., ARRUFFO A., KOLANUS W., BEVILAQUA M. & SEED B. (1990) Recognition by ELAM-1 of the sialyl-Lewis determinant on myeloid and tumor cells. Science 250, 1132.
3. DIAMOND M.S., STAUNTON D.E., DE FOUGEROLLES A.R. et al. (1990) ICAM-1 (CD54) a counter receptor for Mac-1 (CD11b CD18). J Cell Biol 111, 3129.
4. SMITH C.W., ROTHLEIN R., HUGHES B.J. et al. (1988) Recognition of an endothelial determinant for CD 18-dependent human neutrophil adherence and transendothelial migration. J Clin Invest 82, 1746.
5. POBER J.S., GIMBRONE Jr, M.A., LAPIERRE L.A. et al. (1986) Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J Immunol 137, 1893.
6. DUSTIN M.L. & SPRINGER T.A. (1988) Lymphocyte function associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells. J Cell Biol 107, 1321.
7. POBER J.S., BEVILAQUA M.P., MENDRICK D.L., LAPIERRE L.A., FIERS W. & GIMBRONE Jr, M.A. (1986) Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells. J Immunol 136, 1680.
8. BEVILAQUA M.P., POBER D.L., MENDRICK R.S., COTRAN R.S. & GIMBRONE Jr, M.A. (1987) Identification of an inducible endothelial leukocyte adhesion molecule. Proc Natl Acad Sci USA 84, 9238.
9. GOELZ S.E., HESSION C., GOFF D. et al. (1990) ELFT: a gene that directs the expression of an ELAM-1 ligand. Cell 63, 1349.
10. PHILIPS M.L., NUDELMAN E., GAETA F.C.A. et al. (1990) ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand sialyl-Lewis. Science 250, 1130.
11. CARLOS T., KOVACH N., SCHZWARTZ B. et al. (1991) Human monocytes bind to two cytokine-induced adhesive ligands on cultured human endothelial cells: endothelial leukocyte adhesion molecule-1 and vascular cell adhesion molecule-1. Blood 77, 2266.
12. BARNES P.J., GHUNG K.F. & PAGH C.P. (1988) Platelet activating factor as a mediator of allergic disease. J Allergy Clin Immunol 81, 919.
13. BENVENISTE B. & ARNOUX B. (1983) Platelet activating factor and structurally related ether lipids. iNSRM symposium No. 23, Elsevier Science Publishers, Amsterdam.
14. EWANS T.W., CHUNG K.F., ROGERS D.F. & BARNES P.J. (1987) Effect of platelet activating factor on airway vascular permeability: possible mechanisms. J Appl Physiol 63, 479.
15. CUSS F.M., DIXON C.M.S. & BARNES P.J. (1986) Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man. Lancet 2, 189.
16. BENVENISTE J. (1987) A role for PAF acether (platelet activating factor) in bronchial hyperreactivity? Am Rev Respir Dis 135, S2.
17. RUBIN E.A., SMITH L.J. & PATTERSON R. (1987) The bronchocon-strictor properties of platelet activating factor in man. Am Rev Respir Dis 136, 1145.
18. MENICIA-HUERTA J.M., HOSPORD D. & BRAQUET P. (1989) Acute and long term pulmonary effects of platelet activating factor. Clin Exp Allergy 19, 125.
19. SHAW J.O., PINCKARD N., FERRIGNI K.S., MCMANUS L.M. & HANAHAN D.J. (1981) Activation of human neutrophils with 1-o-hexadecyl/octadecyl-2-acetyl-sn-glycerol-3-phosphocholine (platelet activating factor). J Immunol 111, 1250.
20. BUSSOLINO J., CAMUSI G., AGLIETTA M. et al. (1987) Human endothelial cells are target for platelet activating factor. Platelet activating factor induces changes in cytoskeleton structure. J Immunol 139, 2439.
21. BURHOP K.E., GARCIA J.G.N., SELIG W.M. et al. (1986) Platelet activating factor increases lung vascular permeability to protein. J Appl Physiol 61, 2210.
22. GARCIA J.G.N., AZGHANI A., CALLAHAN K.S. & JOHNSON A.R. (1988) Effect of platelet activating factor on leukocyte-endothelial interactions. Thromh Res 51, 83.
23. BRAQUET P., HOSFORD D., BRAQUET M., BOURGAIN R. & BUSSOLINO F. (1989) Role of cytokines and platelet activating factor in microvascular immune injury. Int Arch Allergy Appl Immunol 88, 88.
24. BRAQUET P., PAUBERT-BRAQUET M., BOURGAIN R., BLISSOLINO F. & HOSFORD D. (1989) PAF/cytokine auto-generated feedback networks in microvascular immune injury: consequences in shock, ischemia, and graft rejection. J Lipid Medial 1, 75.
25. SUN X.M. & HSUEH W. (1988) Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet activating factor. J Clin Invest 81, 1328.
26. BUSSOLINO F., CAMUSSI G. & BAGLIONI C. (1988) Synthesis and release of platelet activating factor by human vascular endothelial cells treated with tumor necrosis factor or interleukin 1α. J Biol Chem 263, 11856.
27. HASLETT C., GUTHRIE L.A., KOPANIAK M.M., JOHNSTON R.B. & HENSON P.M. (1985) Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am J Pathol 119, 101.
28. DING Z, LI S. & WU Z. (1992) Mechanisms of endothelial cell-dependent leukocyte adhesion stimulated by platelet activating factor. Inflammation 16, 179.
29. CHIHARA J., MARUYAMA I., YASUBA H, et al. (1992) Possible induction of intracellular adhesion molecule-1 (ICAM-1) expression on endothelial cells by platelet activating factor (PAF). J Lipid Mediat 5, 159.
30. BARTHELSON R. & VALONE F. (1990) Interaction of platelet activating factor with interferon-γ in the stimulation of interleukin-1 production by human monocytes. J Allergy Clin Immunol 886, 193.
31. COUGHLAN A.F., HAU H., DUNLOP L.C., BERNDT M.C. & HANCOCK W.W. (1993) P-selectin and platelet activating factor mediated initial endotoxin-induced neutropenia. J Exp Med 179, 329.
32. MAESTRE C., ZARCO P., GOMEZ-GUERRERO C, et al. (1990) Cooperation between tumor necrosis factor (TNF) and platelet activating factor (PAF) in the inflammatory response. J Lipid Mediat 2, S151.
33. SIROIS M.G., PLANTE G.E., BRAQLIET P. & SIROIS P. (1990) Tumor necrosis factor primes the effects of platelet activating factor on rat vascular permeability. J Lipid Mediators 2 Suppl, S109.
34. WALKER C., BAUER W., MENZ G. et al. (1994) Activated T cells and cytokines in bronchoalveolar lavage from patients with various lung diseases. Am J Respir Crit Care Med 159, 1038.
35. PFEFFER K., MATSUYAMA T., KUNDIG T.M. et al. (1993) Mice deficient for 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73, 457.
36. VERCELOTTI G.M., YIN H.O., GUSTAFSON K.S., NELSON R.D. & JACOB H.S. (1988) Platelet activating factor primes neutrophil responses to agonists: role in promoting neutrophil mediated-endothelial damage. Blood 71, 1110.